Biomarker Analysis Identifies Women Most Likely to Benefit From Kadcyla (05-20-2013)

Among women with metastatic, HER2-positive breast cancer, those with the highest tumor HER2 levels benefit the most from the drug Kadcyla™ (ado-trastuzumab emtansine, formerly known as T-DM1), according to the results of a study presented at the American... Continue Reading

Novel Two-step Immunotherapy Shows Promise in Recurrent Ovarian Cancer (05-17-2013)

A novel two-step immunotherapy approach yielded clinically beneficial responses in patients with advanced ovarian cancer, according to data from two phase I clinical trials presented at the American Association for Cancer Research (AACR) Annual Meeting... Continue Reading

Following Lifestyle Recommendations Reduces Risk of Cancer Death (05-15-2013)

People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying from several diseases and specifically, a 20 percent... Continue Reading

Genomic Test May Help Guide Prostate Cancer Treatment (05-13-2013)

A new genetic test—the Oncotype DX® Prostate Cancer Test—measures the aggressiveness of prostate cancer and may help scores of men choose between immediate treatment or active surveillance. The test was shown to strongly predict aggressiveness of... Continue Reading

Statins Linked to Lower Risk of Liver Cancer in Hepatitis C (05-8-2013)

People infected with chronic hepatitis C are less likely to develop liver cancer if they are taking statins (cholesterol-lowering drugs), according to the results of a study published in the Journal of Clinical Oncology.[1] The liver is the largest organ... Continue Reading

Anal Cancer Rates Appear to Be On the Rise in the U.S. (05-6-2013)

The number of people in the United States with anal cancer has tripled since the 1970s, according to the results of a study published in the Journal of Clinical Oncology. Anal cancer is an uncommon type of cancer that occurs in the anal canal, the opening... Continue Reading

False-Positive Mammograms Leave a Long-Term Psychological Impact (05-3-2013)

A false-positive mammogram can cause long-term psychosocial harm, according to the results of a study published in the Annals of Family Medicine—in fact, three years later, women still suffer the psychological after-effects of the scare. A mammogram... Continue Reading

Number of Cancer Survivors Expected to Reach 18 Million by 2022 (05-1-2013)

As of January 2012, there were approximately 13.7 million cancer survivors in the United States and that number is expected to rise by 31 percent to 18 million by 2022, according to the second Annual Report on Cancer Survivorship in the United States published... Continue Reading

HPV Test Appropriate After Indeterminate Pap Test (04-29-2013)

Women who have an indeterminate Pap smear should undergo human papillomavirus (HPV) testing rather than another Pap smear, according to the results of Cochrane Review. Cancer screening refers to the use of tests to detect cancer in individuals who do... Continue Reading

Combined Hormone Replacement Therapy Linked to Increased Risk of Breast Cancer (04-26-2013)

The use of combined hormone replacement therapy with estrogen plus progestin among postmenopausal women was associated with an increased risk of breast cancer, according to the results of a long-term analysis published in the Journal of the National Cancer... Continue Reading

Screening Could Reduce Lung Cancer Mortality (04-24-2013)

Screening for lung cancer with low-dose computed tomography (LDCT) in all screening-eligible current and former smokers could potentially avert approximately 12,000 lung cancer deaths each year in the United States, according to the results of a study... Continue Reading

Second Large Study Confirms Oncotype DX Can Predict Recurrence in Stage 2 Colon Cancer (04-22-2013)

Results from the large CALGB 9581 clinical validation study of the Oncotype DX® colon cancer test confirm that Recurrence Score® (RS) results improve the ability to differentiate high recurrence risk disease from low recurrence risk disease, beyond... Continue Reading